Skip to content

To Analyse The Anxiety Effect Of Midazolam In Cesarean Section

Study To Evaluate The Anxiolytic Effect Of Midazolam In Patients Of Cesarean Section: A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089237
Enrollment
160
Registered
2025-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: prophylactic injection prior to spinal anaesthesia: Single intravenous Bolus Of Midazolam 0.0125mg/kg Before The Spinal Anaesthesia , Dose - 0.0125 mg/kg ,Route - Intravenous , Single

Sponsors

Sawai Man Singh Medical College Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients Undergoing Cesarean Section 2. Patients Giving Informed Written Consent 3. Patients Belonging To American Society Of Anaesthesiologist Physical Status 2

Exclusion criteria

Exclusion criteria: 1. Pregnant Woman With Under Developed Fetus Or With Malformation 2. Pregnant Woman With Acute Fetal Distress 3. Pregnant Woman With Multiple Pregnancy 4. Pregnant Woman With Cardiac Disorder Moderate To Lung Disorder Moderate to Severe Psychopathologies Pregnancy Induced Hypertension Coagulopathies Allegic To Drugs Local Infection at site Spinal Deformities 5. Patient Should Not Be A Part Of Any Other Study

Design outcomes

Primary

MeasureTime frame
To Asses And Compare Anxiolytic Effect Of With Or Without Midazolam In Patients Of Cesarean SectionTimepoint: 90 Minutes

Secondary

MeasureTime frame
1.To Asses And Compare APGAR Ramsay Sedation Scale Recall Of MomentsOf Birth In Study Groups 2. To Determine The Change In Hemodynamic Parameter HR SBP DBP SPO2 3.Proportion Of Cases Of Complication ( If Any)Timepoint: 90 Minutes

Countries

India

Contacts

Public ContactDr Rohit Bairwa

Sawai Man Singh Medical College Jaipur

trishala.jain31@gmail.com9414281744

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026